Compare Jaya Konstruksi Manggala Pratama Tbk (JKON) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jaya Konstruksi Manggala Pratama Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Jaya Konstruksi Manggala Pratama Tbk trades at Rp88 (market cap 1.42T, 9.95M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp166 (market cap 651.75B, 666.4K 24h volume). The key difference: Jaya Konstruksi Manggala Pratama Tbk is far larger — about 2.2× UBC Medical Indonesia Tbk.'s market cap, and Jaya Konstruksi Manggala Pratama Tbk is more actively traded (9.95M versus 666.4K). Which is the better fit depends on your goals.
| JKON | LABS | |
|---|---|---|
Market Cap | 1.42T | 651.75B |
Volume | 9.95M | 666.4K |
Lot | 99.45K | 6.66K |
Turnover | 864.56M | 110.15M |
Average Price | 86.93 | 165.3 |
Value | 864.56M | 110.15M |
Indicative Equilibrium Price | 88 | 165 |
Indicative Equilibrium Volume | 3.17K | 300 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jaya Konstruksi Manggala Pratama Tbk
PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.
Read more on JKON →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
